BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8847478)

  • 1. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
    Avramoglu RK; Cianflone K; Sniderman AD
    J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
    Wu X; Sakata N; Lui E; Ginsberg HN
    J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
    J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
    Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
    J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
    Carr TP; Hamilton RL; Rudel LL
    J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
    Graham A; Wood JL; Russell LJ
    Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
    Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
    Brown A; Wiggins D; Gibbons GF
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
    Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
    Borradaile NM; de Dreu LE; Barrett PH; Huff MW
    J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.
    Craig WY; Cooper AD
    J Lipid Res; 1988 Mar; 29(3):299-308. PubMed ID: 2837527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
    Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
    Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis.
    Ooyen C; Zecca A; Zanelli T; Catapano AL
    Atherosclerosis; 1997 Apr; 130(1-2):143-52. PubMed ID: 9126658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
    Dashti N; Franklin FA; Abrahamson DR
    J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
    J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K; Avramoglu RK; Sawyez C; Huff MW
    Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes.
    Tanaka M; Jingami H; Otani H; Cho M; Ueda Y; Arai H; Nagano Y; Doi T; Yokode M; Kita T
    J Biol Chem; 1993 Jun; 268(17):12713-8. PubMed ID: 8509406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Wilcox LJ; Borradaile NM; de Dreu LE; Huff MW
    J Lipid Res; 2001 May; 42(5):725-34. PubMed ID: 11352979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.